g-csf
Showing 26 - 50 of 156
Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)
Active, not recruiting
- Mantle-Cell Lymphoma
- G-CSF
- +10 more
-
Miami, FloridaUniversity of Miami
Aug 12, 2021
Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- Cladribine Injection
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 15, 2020
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Cyclophosphamide
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)
Recruiting
- Leukemia, Monocytic, Acute
- Pediatric AML
- Cladribine
- +5 more
-
Foshan, Guangdong, China
- +8 more
Mar 28, 2022
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)
Recruiting
- Leukemia, Myeloid, Acute
- Idarubicin
- +5 more
-
Badalona, Barcelona, Spain
- +14 more
Jul 30, 2021
Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)
Completed
- Hematologic Malignancies
- Stem Cell Transplant
- +5 more
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Oct 30, 2020
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Lymphoma Trial in Minneapolis (drug, procedure, radiation, biological)
Completed
- Lymphoma
- carmustine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jul 10, 2020
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- fludarabine phosphate
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)
Completed
- Lymphoma
- Cyclophosphamide
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2020
Systemic Sclerosis, Scleroderma Trial in Chicago (Rituximab, Fludarabine, Cyclophosphamide)
Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell
Active, not recruiting
- Leukemia
- +9 more
- Fludarabine monophosphate
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 2, 2020
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)
Completed
- Hodgkin Lymphoma
- brentuximab vedotin
- +9 more
-
Argenteuil, France
- +29 more
Jul 23, 2021
Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)
Completed
- Myeloma
- Palifermin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 23, 2020
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)
Unknown status
- Acute Myeloid Leukemia
- Relapse Leukemia
- Cladribine
- +3 more
-
Guangzhou, Guangdong, ChinaLiang Wang
Aug 18, 2019
Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)
Unknown status
- Acute Lymphoblastic Leukemia
- Cladribine
- +3 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 18, 2019